Testing effectiveness (Phase 2)Study completedNCT00039364
What this trial is testing
Imatinib Mesylate in Treating Patients With Gliomas
Who this might be right for
Brain and Central Nervous System Tumors
European Organisation for Research and Treatment of Cancer - EORTC 112